Luca Quagliata

Private Equity Investor chez

Xgen Venture Sgr SpA

Consumer Services

Finance

Profil

Dr Luca Quagliata joined XGEN as Venture Partner in 2023.
Luca is VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific.
Before joining Thermo Fisher, Luca worked as Senior Director and Team Leader of the Molecular Diagnostics Division at the Institute of Pathology, University Hospital Basel, Switzerland.
Luca is trained in Medical Biotechnology (Naples, Italy), holds a Ph.D.
in Vascular Medicine (Heidelberg, Germany), a Certificate of Achievement (COA) in Genetics (Harvard, Boston), was a visiting fellow at the NCI-NIH (Bethesda, USA), and is a Board-Certified Specialist in Medical Affairs (BCMAS).

Postes actifs de Luca Quagliata

Sociétés	Poste	Début
Xgen Venture Sgr SpA Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions.	Private Equity Investor	01/01/2023

Tous les postes actifs de Luca Quagliata

Formation de Luca Quagliata

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Luca Quagliata

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
Heidelberg University (Ohio) Heidelberg University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Università degli Studi di Napoli Federico II Università degli Studi di Napoli Federico II Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xgen Venture Sgr SpA Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions.	Finance